We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAOX
3326
Tao Synergies Inc
TAOX
$28.9M
-1,688
Closed -$11.5K
SOUN icon
3327
SoundHound AI
SOUN
$3.25B
-143,044
Closed -$303K
SPIR icon
3328
Spire Global
SPIR
$566M
-17,156
Closed -$134K
SPXL icon
3329
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.97B
-4,780
Closed -$497K
SR icon
3330
Spire
SR
$4.78B
-16,989
Closed -$1.06M
SSD icon
3331
Simpson Manufacturing
SSD
$7.74B
-2,001
Closed -$396K
STGW icon
3332
Stagwell
STGW
$2.13B
-100,971
Closed -$669K
STIM icon
3333
Neuronetics
STIM
$229M
-30,995
Closed -$89.9K
STNG icon
3334
PUT
Scorpio Tankers
STNG
$3.93B
-993,900
Closed -$60.4M
STZ icon
3335
Constellation Brands
STZ
$23.2B
-18,385
Closed -$4.44M
SUP
3336
DELISTED
Superior Industries International
SUP
-11,200
Closed -$35.8K
SUSL icon
3337
iShares ESG MSCI USA Leaders ETF
SUSL
$1.22B
-6,000
Closed -$506K
SVII
3338
DELISTED
Spring Valley Acquisition Corp II
SVII
-500,000
Closed -$5.41M
SYLD icon
3339
Cambria Shareholder Yield ETF
SYLD
$1.03B
-16,800
Closed -$1.14M
TAK icon
3340
Takeda Pharmaceutical
TAK
$58.1B
-33,550
Closed -$479K
TAOP icon
3341
Taoping
TAOP
$8.12M
-655
Closed -$28.5K
TBPH icon
3342
Theravance Biopharma
TBPH
$883M
-38,939
Closed -$438K
TC
3343
TuanChe
TC
$54.7M
-242
Closed -$14.8K
TCRT icon
3344
Alaunos Therapeutics
TCRT
$4.47M
-2,010
Closed -$21.3K
TECK icon
3345
Teck Resources
TECK
$33.9B
-141,493
Closed -$5.98M
TENX icon
3346
Tenax Therapeutics
TENX
$65.5M
-1,780
Closed -$39.1K
TEO icon
3347
Telecom Argentina
TEO
$5.66B
-22,291
Closed -$159K
TGNA
3348
DELISTED
TEGNA Inc
TGNA
-50,841
Closed -$778K
THC icon
3349
Tenet Healthcare
THC
$22.6B
-28,500
Closed -$2.15M
THR
3350
DELISTED
Thermon Group Holdings
THR
-29,918
Closed -$974K

Similar funds

John Overdeck's Q1 2024 Portfolio in Review

As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, John Overdeck opened a new position in Pfizer worth $234M.

  • John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
  • John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • John Overdeck opened 408 new positions and closed 532 in Q1 2024.
  • John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.